The gene expression profiling of endometriotic lesions and the parallel CECs samples from peripheral blood identified a range of potential biomarkers including the elevated gene expression of NANOG, KRT18, and VIM or of KRT19 and ESR1 that may be used to identify CECs in the patients with undiagnosed endometriosis [35]. The gene discussed is KRT19; the disease is endometriosis.